STUDresearch · Peptide
Taxorest
Also known as
A-19 · A-19 lung bioregulator · lung cytomax · bronchial cytomax · Khavinson lung complex · Taxorest peptide
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Systemic
Oral
Organ bioregulators
Systemic oral animal-lung tissue peptide extract sold as organ-targeted support; human efficacy and pharmacokinetics remain very thin.
What people say
An oral peptide mixture extracted from animal bronchial tissue and marketed as Taxorest/A-19 for lung-focused support. It is not a defined synthetic molecule or an approved asthma/COPD treatment.
Doses people talk about
Rows preserve the product schedules as marketing or study-report context, not validated pulmonology dosing. Chonluten SubQ charts are a different molecule class.
How it may feel
No isolated Taxorest feel pattern or onset was established. Commercially linked diaries describe respiratory improvement, but they also switched products or used KPV and other interventions.
Study-report-style course10 mg orally twice daily with meals for 30 days
One capsule per administration in the preserved report-style schedule, added to usual respiratory care.
Broader product chart10 mg per capsule; 1–2 capsules once or twice daily with meals
A manufacturer-associated 30-day chart, not a controlled dose-finding result.
Half-life & effect duration
- Half-life in the body
- Oral peptide complexNo settled estimate
- Felt duration people report
- Broader peptide-program accountsRespiratory improvement, without an isolated Taxorest timeline
Cycles people discuss
Manufacturer-associated material describes a 30-day oral course and repeats after months; one older diary describes three courses a year. These schedules are not PK-derived.
Timing
Oral capsule charts use 1–2 capsules once or twice daily with meals for about 30 days. The only long public diary described three courses a year alongside vessel and thymus cytomaxes; that is a stacked anecdote, not a universal repeat schedule.
Stacks
Ventfort and Vladonix appear in an older diary, while Chonluten/Bronchogen are often compared or substituted. These are not established Taxorest combinations.
Watch for
Regulatory: Not an approved COPD/asthma drug.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No route-specific human parent-component half-life was established for Taxorest A-19.
The inspected brochure identifies an animal bronchial-mucosa peptide complex and gives oral course instructions, but no concentration-time or clearance study.
Taxorest is a mixture rather than one defined sequence; a limited public search does not prove no historical data exist. Chonluten or Bronchogen kinetics cannot be imported.
- Reports on clinical use of peptide bioregulators: Taxorest section (opens in a new tab)Taxorest page identifying a peptide complex from bronchial mucosa and instructions of 1–2 capsules or tablets 1–2 times daily with meals for 30 days, with a 4–6-month repeat suggestion.Manufacturer-associated brochure with brief study claims, no transparent controlled trial report or human pharmacokinetic table.
Felt duration people report
No dependable Taxorest-specific onset or felt-duration clock was established.
Two commercially connected first-person sources describe respiratory improvement across broader peptide programs, but one switched from Taxorest to Chonluten/LunGuard and both mention KPV or other interventions.
Commercial/affiliate conflict, product switching, multiple co-interventions, no verified diagnosis or objective chronology, and no independent same-product replication.
- Peptide Diary: lungs entry (opens in a new tab)Day 14 lungs entry: author reports allergy-induced asthma history, says lung bioregulators were helpful, began with Taxorest, switched to Chonluten, later favored LunGuard and also credited KPV.Commercial/affiliate links, several products, no verified medical records, no dose-isolated Taxorest timeline and no controlled comparator.
- Healing with Peptides: Taxorest and Chonluten experience (opens in a new tab)Taxorest/Chonluten section describing the author’s asthma story, product switching, roughly six months of sublingual use, later microdosing, KPV use and a claimed 30% improvement.Commercial sourcing links and family treatment advocacy; multiple interventions, product identity shifts and no independent objective verification.
What people say
- Breathing comfort (n=1): The 2-year, 3×/year X log is the loudest personal claim. Ventfort and Vladonix rode along. anecdote
- Search intent: People with dust/asthma/post-infection stories hunt a “lung bioregulator”; Chonluten diaries often steal the oxygen in those threads. forum
- Immortalists-list cameo: Taxorest shows up on “peptides slow aging” roundups as the lung name, next to Stamakort and Svetinorm. List ≠ evidence. forum
- Chronic bronchitis adjunct (originating-group): Capsule add-on to general therapy in older Russian product literature — bronchial mucosa “reserve,” adaptive capacity language. trial
- What is missing: Public FEV1/FVC logs, 6-minute walk, or independent RCTs named Taxorest. trial
Doses people talk about
- Capsule: 10 mg active complex in the classic product literature. forum
- Broad chart: 1–2 capsules, 1–2 times daily, ~30 days. forum
- Cadence in the long n=1: Three courses a year, stacked with vessel and thymus cytomaxes. anecdote
- Do not import Chonluten 10–20 mg subq EOD charts. Different molecule class. forum
- Framing: Cytomax charts and one long X diary — not pulmonology dosing. forum
- Study-report style: 1 capsule 2 times a day at meals for 30 days, added to usual respiratory care. trial
How it may feel
- Days 1–7: Capsule. Not albuterol-in-20-minutes. forum
- End of 30 days: Study-report and retail checkpoint. forum
- Seasonal re-runs: The 3×/year for 2 years story. anecdote
- If you still need the rescue inhaler daily: That’s the honest Chonluten-thread warning too — keep the controller. forum
- Experience reports: One ongoing recovery diary said lung bioregulators were helpful, beginning with Taxorest before switching to Chonluten and later favoring LunGuard; the same account also credited KPV. Another commercially linked family-health blog described Taxorest/Chonluten use over months alongside KPV and other interventions. Neither source isolates Taxorest or supplies a dependable onset. anecdote
Cycles people discuss
- 30-day oral block is the literature/retail default. forum
- A few times per year in the only long public diary. anecdote
- Not a daily forever lung vitamin. forum
Timing
- With meals: Chart default. forum
- Not a bronchodilator clock. forum
- PK honesty: No public human PK for A-19. trial
- Course logic: Tissue-complex / gene-expression framing, same family as Chonluten lore but a different product. forum
More on what it is
- What it is: Natural peptide complex from bronchial mucosa, Khavinson cytomax A-19. Tissue-extract class — not the synthetic tripeptide Chonluten (EDG) and not Bronchogen (AEDL). forum
- Why people search it: r/Peptides “any peptides for lungs/breathing” threads; one 2025 post named A-19 Taxorest as the most promising after early reading. forum
- Long n=1: A 2026 X user said they ran Taxorest 3 times a year for 2 years with Ventfort and Vladonix for a rare lung disease — “changed the quality of my life massively.” Single voice, stacked, no spirometry attached. anecdote
- vs Chonluten / Bronchogen: Those two are short synthetics with more English peptide-Twitter airtime. Taxorest is the cytomax name. Do not copy 10–20 mg Chonluten inject charts onto A-19 capsules. forum
- Not: Not a rescue inhaler, steroid, oxygen, or antifibrotic. forum
- Originating-group add-on: Antiaging-systems-style clinical notes describe 1 capsule 2×/day × 30 days on top of usual care in chronic bronchitis of various origins. trial
Stacks
- Ventfort + Vladonix: The 2-year X trio. anecdote
- Chonluten / Bronchogen: People compare or accidentally double the “lung” slot. forum
- Not a skip-the-inhaler stack. forum
Storage notes
- Capsules: Dry storage per the bottle. forum
- No mix instructions here: STUDresearch does not list reconstitution charts. forum
Watch for
- Vendor tone: Well-tolerated capsule story. Independent AE databases are not a thing here. forum
- GI: Capsule. forum
- Animal-tissue complex. forum
- Breathing emergency: Blue lips, can’t speak, silent chest — EMS, not A-19. forum
- Keep the inhaler / oxygen / specialist meds. forum
- Smoking while “repairing”: Even sympathetic protocol pages doubt that combo. forum
- Regulatory: Not an approved COPD/asthma drug. trial
- Research-only framing: Discussion of community practice — not a recommendation to use in humans or animals. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.